ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Investigating the efficacy and mechanisms of Jinfu'an decoction in treating non-small cell lung cancer using network pharmacology and in vitro and in vivo experiments

Peng, Huiting; Huang, Zhongming; Li, Peiqin; Sun, Zhe; Hou, Xuenan; Li, Zeyun; Sang, Ran; Guo, Zehuai; Wu, Siqi; Cao, Yang*广州中医药大学; 汕头大学; 1; y
Journal of Ethnopharmacology2024-3-1DOI: 10.1016/j.jep.2023.117518
9阅读
引用收藏
分享

摘要

Ethnopharmacological relevance: Jinfu'an Decoction (JFAD) is a traditional Chinese decoction used in lung cancer treatment to improve patient quality of life and survival. Previous research has established that JFAD has a significant therapeutic effect on non-small cell lung cancer (NSCLC), although the underlying molecular mechanisms have not been largely underexplored.Aim of the study: We used network pharmacology to identify the putative active ingredients of JFAD and conducted experimental studies to determine the potential molecular mechanism of JFAD in NSCLC treatment.Materials and methods: The herbal components in JFAD-containing serum were identified by ultra-high performance liquid chromatography-quadrupole time-of-flight mass spectrometry (UHPLC-QTOF-MS), and targets associated with the anti-lung cancer metastasis effects of JFAD were retrieved from various databases. The Database for Annotation, Visualization and Integrated Discovery (DAVID) was used to perform Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis. Next, the protein-protein interactions network and the "JFAD-Chemical Component-Target-KEGG Pathway" network were constructed. The network pharmacology findings were confirmed by in vitro and in vivo experiments. In vitro experiments were conducted to assess cell viability by CCK8 assay, cell cycle analysis by propidium iodide (PI) assay, and migration and invasion ability of cells by the transwell assay. In vivo experiments were performed to assess the efficacy of JFAD on the tumor by observing the growth of transplanted tumor models in nude mice and evaluated by in vivo bioluminescence imaging. Moreover, we assessed the effect of JFAD on the PI3K/Akt signaling pathway and proteins of Lumican, p120ctn, and specific RhoGTP enzyme family members (RhoA, Rac1, and RhoC) by Western Blot and immunohistochemistry.Results: 32 herbal components were identified in the JFAD-containing serum, which potentially acted on 229 targets related to lung cancer metastasis. Network pharmacology results suggested that JFAD may treat lung cancer metastasis by targeting the PI3K/Akt pathway via regulating multiple core targets. Our experiments showed that JFAD suppressed the proliferation of A549 cells in vitro, induced cell cycle arrest, and reduced the migration and invasion ability of A549 cells. Our in vivo study revealed that JFAD inhibited tumor growth in a nude mouse model. Additionally, we found that JFAD could downregulate the expression of the PI3K/Akt pathway and affect the expression of Lumican, p120ctn, and specific RhoGTPase family members.Conclusions: In conclusion, through network pharmacology, we have unveiled the underlying mechanisms that link the various components, targets, and pathways influenced by JFAD in the context of lung cancer metastasis. Our experimental results suggest that the oncostatic effects of JFAD may be achieved by upregulating the

学科与关键词

关键词
Jinfu 'an decoctionNetwork pharmacologyp120ctn /LumicanNSCLCUHPLC-QTOF-MS
相关
加载中…
  • A Mechanism Exploration for the Yi-Fei-San-Jie Formula against Non-Small-Cell Lung Cancer Based on UPLC-MS/MS, Network Pharmacology, and In Silico Verification
    Hu, Leihao; He, Canfeng; Mo, Aier; Zhan, Xingkai; Yang, Caizhi; Guo, Wei; Sun, Lingling; Su, Weiwei*; Lin, Lizhu*Evidence-based Complementary and Alternative Medicine, 2023, 2023: 3436814.被引 1
  • Decoding the key compounds and mechanism of Shashen Maidong decoction in the treatment of lung cancer
    Cai, Jieqi; Chen, Yupeng; Wang, Kexin; Li, Yi; Wu, Jie; Yu, Hailang; Li, Qingping; Wu, Qi; Meng, Wei; Wang, Handuo; Lu, Aiping; Huang, Mianbo*; Wei, Genxia*; Guan, Daogang*BMC Complementary Medicine and Therapies, 2023, 23(1): 158.被引 2
  • Determining the mechanism of action of the Qishan formula against lung adenocarcinoma by integration of network pharmacology, molecular docking, and proteomics
    Geng, Xue; Chi, Wencheng; Lin, Xiaoyue; Niu, Zeji; Jiang, Qinghui; Sui, Yutong; Jiang, Jiakang*Medicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries, 2023, 102(13).
查看全部 →

发表信息

论文状态
公开发表
期刊
Journal of Ethnopharmacology
发表日期
2024-03-01
卷期
第 321 卷
页码
117518
DOI
10.1016/j.jep.2023.117518
语言
ENGLISH
成果收录
SCIE
资助标注
National Natural Science Fundation of China [82174456]

作者

  • P

    Peng, Huiting (第一作者)

    1 · guangzhou univ chinese med

  • H

    Huang, Zhongming

    shantou univ

查看全部 10 位作者收起作者
  • L

    Li, Peiqin

    1 · guangzhou univ chinese med

  • S

    Sun, Zhe

    1 · guangzhou univ chinese med

  • H

    Hou, Xuenan

    1 · guangzhou univ chinese med

  • L

    Li, Zeyun

    1 · guangzhou univ chinese med

  • S

    Sang, Ran

    1 · guangzhou univ chinese med

  • G

    Guo, Zehuai

    1 · guangzhou univ chinese med

  • W

    Wu, Siqi

    1 · guangzhou univ chinese med

  • C

    Cao, Yang (通讯)

    1 · guangzhou univ chinese med

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417